Columbia Overseas Value Fund | Quarterly Report 2019 | 1 |
2 | Columbia Overseas Value Fund | Quarterly Report 2019 |
Exchange-Traded Equity Funds 0.3% | ||
Shares | Value ($) | |
United States 0.3% | ||
iShares MSCI EAFE ETF | 76,080 | 5,187,135 |
Total Exchange-Traded Equity Funds (Cost $4,688,050) | 5,187,135 | |
Money Market Funds 1.1% | ||
Columbia Short-Term Cash Fund, 1.745%(e),(f) | 21,682,828 | 21,682,828 |
Total Money Market Funds (Cost $21,682,084) | 21,682,828 | |
Total Investments in Securities (Cost $1,893,524,955) | 1,901,580,590 | |
Other Assets & Liabilities, Net | 7,621,603 | |
Net Assets | $1,909,202,193 |
Forward foreign currency exchange contracts | |||||
Currency to be sold | Currency to be purchased | Counterparty | Settlement date | Unrealized appreciation ($) | Unrealized depreciation ($) |
70,493,000 CAD | 53,701,151 USD | Goldman Sachs | 12/19/2019 | 620,616 | — |
4,286,000 GBP | 5,542,042 USD | Goldman Sachs | 12/19/2019 | — | (5,271) |
97,447,000 ILS | 27,670,443 USD | Goldman Sachs | 12/19/2019 | — | (399,339) |
1,995,628,000 JPY | 18,426,154 USD | Goldman Sachs | 12/19/2019 | 160,271 | — |
1,039,961,000 JPY | 9,498,062 USD | Goldman Sachs | 12/19/2019 | — | (20,649) |
21,587,090,000 KRW | 18,418,233 USD | Goldman Sachs | 12/19/2019 | 132,802 | — |
73,844,413 USD | 107,572,000 AUD | Goldman Sachs | 12/19/2019 | — | (1,048,289) |
5,713,579 USD | 5,704,000 CHF | Goldman Sachs | 12/19/2019 | 792 | — |
18,425,009 USD | 18,175,000 CHF | Goldman Sachs | 12/19/2019 | — | (216,965) |
18,451,994 USD | 16,518,000 EUR | Goldman Sachs | 12/19/2019 | — | (228,064) |
11,069,093 USD | 106,353,000 SEK | Goldman Sachs | 12/19/2019 | 49,876 | — |
Total | 964,357 | (1,918,577) |
Call option contracts written | ||||||||
Description | Counterparty | Trading currency | Notional amount | Number of contracts | Exercise price/Rate | Expiration date | Premium received ($) | Value ($) |
Puma Biotechnology, Inc. | Deutsche Bank | USD | (390,039) | (411) | 10.00 | 12/20/2019 | (24,266) | (43,155) |
(a) | Non-income producing investment. |
(b) | Represents fair value as determined in good faith under procedures approved by the Board of Trustees. At November 30, 2019, the total value of these securities amounted to $4, which represents less than 0.01% of total net assets. |
(c) | Valuation based on significant unobservable inputs. |
(d) | This security or a portion of this security has been pledged as collateral in connection with derivative contracts. |
(e) | The rate shown is the seven-day current annualized yield at November 30, 2019. |
Columbia Overseas Value Fund | Quarterly Report 2019 | 3 |
(f) | As defined in the Investment Company Act of 1940, an affiliated company is one in which the Fund owns 5% or more of the company’s outstanding voting securities, or a company which is under common ownership or control with the Fund. Holdings and transactions in these affiliated companies during the period ended November 30, 2019 are as follows: |
Issuer | Beginning shares | Shares purchased | Shares sold | Ending shares | Realized gain (loss) — affiliated issuers ($) | Net change in unrealized appreciation (depreciation) — affiliated issuers ($) | Dividends — affiliated issuers ($) | Value — affiliated issuers at end of period ($) |
Columbia Short-Term Cash Fund, 1.745% | ||||||||
9,754,825 | 272,567,691 | (260,639,688) | 21,682,828 | (666) | 744 | 165,299 | 21,682,828 |
ADR | American Depositary Receipt |
AUD | Australian Dollar |
CAD | Canada Dollar |
CHF | Swiss Franc |
EUR | Euro |
GBP | British Pound |
ILS | New Israeli Sheqel |
JPY | Japanese Yen |
KRW | South Korean Won |
SEK | Swedish Krona |
USD | US Dollar |
4 | Columbia Overseas Value Fund | Quarterly Report 2019 |